投稿问答最小化  关闭

万维书刊APP下载
您的位置:万维书刊网 >> 期刊动态

AMERICAN JOURNAL OF VETERINARY RESEARCH《美国兽医研究杂志》投稿须知(官网信息)

2021/6/17 15:11:05 来源:官网信息 阅读:538 发布者:
编者按:以下信息,由万维书刊网根据期刊官网信息整理发布!仅供投稿参考!

AJVR Instructions for Authors June 2021

The American Journal of Veterinary Research is a monthly, peer-reviewed, veterinary medical journal owned by the American Veterinary Medical Association that publishes reports of original research and review articles in the general area of veterinary medical research.

MISSION

The mission of the American Journal of Veterinary Research is to publish, in a timely manner, peer-reviewed reports of the highest quality research that has the clear potential to enhance the health, welfare, and performance of animals and humans. The journal will maintain the highest ethical standards of scientific journalism and promote such standards among its contributors. In addition, the journal will foster global interdisciplinary cooperation in veterinary medical research.

SCOPE

The American Journal of Veterinary Research supports the collaborative exchange of information between researchers and clinicians by publishing novel research findings that bridge the gulf between basic research and clinical practice or that help to translate laboratory research and preclinical studies to the development of clinical trials and clinical practice. The journal welcomes submission of high-quality original studies and review articles in a wide range of scientific fields, including anatomy, anesthesiology, animal welfare, behavior, clinical pathology, epidemiology, genetics, infectious disease, microbiology, molecular biology, oncology, pharmacology, pathogenic mechanisms, physiology, surgery, theriogenology, toxicology, and vaccinology. Species of interest include production animals, companion animals, equids, exotic animals, birds, reptiles, and wild and marine animals. Reports of laboratory animal studies and studies involving the use of animals as experimental models of human diseases are considered only when the study results are of demonstrable benefit to the species used in the research or to another species of veterinary interest. Other fields of interest or animal species are not necessarily excluded from consideration, but such reports must focus on novel research findings. Submitted papers must make an original and substantial contribution to the veterinary medicine knowledge base; preliminary or pilot studies are not appropriate.

EDITORIAL POLICIES

Authorship

Individuals should be listed as authors only if they (1) made a substantial contribution to the conception and design of the study, the acquisition of the data used in the study, or the analysis and interpretation of that data; (2) were involved in drafting or revising the manuscript critically for important intellectual content; and (3) approved the submitted version of the manuscript and will have an opportunity to approve subsequent revisions of the manuscript, including the version to be published. All 3 conditions must be met. Each individual listed as an author must have participated sufficiently to take public responsibility for the work. Acquisition of funding, collection of data, or general supervision of the research team does not, alone, justify authorship. Requests to list a working group or study group in the byline will be handled on a case-by-case basis. All authors must complete and submit the Copyright Assignment Agreement and Authorship Form (jav.ma/CAA-AF), confirming that they meet the criteria for authorship. If a manuscript describes clinical treatments or clinical interpretations, at least 1 author must be a veterinarian.

Compounding

Manuscripts describing studies that involved administration of compounded products should include in the Materials and Methods section a complete description of each compounded product, including identities and sources of the active and inactive ingredients, concentration of each ingredient, and, if available, stability data for each product such that the compounded product may be replicated if needed.

Conflicts of interest and financial disclosures

A conflict of interest exists whenever an individual has financial interests or personal relationships that might consciously or unconsciously influence their decisions. Conflicts of interest are ubiquitous and cannot be completely eliminated; they do not, by themselves, indicate improper behavior, wrongdoing, or scientific misconduct.

Financial relationships are the most easily identifiable conflicts of interest and include, among other things, ownership, employment, consultancies, honoraria, paid expert testimony, grants, patents, stock ownership or options, and service as an officer or board member. Other conflicts of interest include personal and professional relationships, academic competition, and intellectual beliefs.

All authors must disclose in the Acknowledgments section of the manuscript any financial or personal relationships that could be perceived to influence or could give the appearance of influencing information in the submitted manuscript. This includes detailed information about all relevant financial interests, activities, relationships, and affiliations (other than affiliations listed on the title page of the manuscript) occurring at the present time or within the 3 years prior to manuscript submission. In this context, relevant financial interests, activities, relationships, and affiliations should be interpreted broadly. For example, authors should disclose relationships they have not only with companies that manufacture products that are the subject of research described in the manuscript but also with companies that manufacture competing products. If no such conflicts of interest existed, the following statement or an equivalent should be included: The authors declare that there were no conflicts of interest.

The scientific editors reserve the right to reject any manuscript because of conflicts of interest. Failure to fully disclose conflicts of interest may be grounds for rejection or retraction of the manuscript.

Copyright

The AJVR is covered by copyright. All authors will be required to transfer copyright to the AVMA prior to publication of any manuscript or letter by completing and submitting the Copyright Assignment Agreement and Authorship Form (jav.ma/CAA-AF). Requests to copy, reprint, or use portions of published material (including information in figures, appendices, and tables) should be addressed to the editor-in-chief.

Authors must obtain and submit a statement of permission from the copyright holder (most often, the author or publisher) if they wish to include an exact duplicate or a slightly modified version of items such as figures, appendices, or tables that appeared or will have appeared in other published reports prior to publication of the manuscript, regardless of the originating source.

Original artwork (eg, drawings or photographs) that was created specifically for use in the manuscript must be accompanied by a letter explaining the conditions under which the work was created. The letter must be signed by the artist and specify the rights given to the authors for use of the artwork and the rights retained by the artist (if any). If rights are retained by the artist, the letter must include a statement that allows the journal to use the material for publication in print and online.

If diagnostic images (eg, radiographic, CT, MRI, and histologic images) that were not prepared by the authors or their institution are included in the manuscript, the authors must include a statement from the copyright holder that allows the journal to use the images for publication in print and online.

Dual-use research of concern

Openness is recognized as a priority when making decisions regarding scientific publishing. Advances in molecular and cellular biology, genetics, microbiology, and other life sciences have made it increasingly possible to manipulate aspects of biological systems to better understand healthy states and mechanisms of disease. However, these advances have also increased the potential that information, products, or technologies resulting from life sciences research may be misused for harmful purposes. The US National Science Advisory Board for Biosecurity has proposed the following definition for dual-use research:

Dual-use research of concern is research that, based on current understanding, can be reasonably anticipated to provide knowledge, products, or technologies that could be directly misapplied by others to pose a threat to public health, safety, agricultural crops and other plants, animals, the environment, or material.

Accordingly, the AJVR has adopted the following policy regarding assessment of submitted manuscripts with potential dual-use content:

Any manuscript submitted for publication that raises concerns regarding dual-use potential will be subject to editorial review to determine the risks and benefits to the scientific community and to the public at large that may result from publication. The AVMA scientific editors maintain a strong commitment against withholding scientific or other information unless there are compelling reasons to do so.

The scientific editors reserve the right to seek special external review of these manuscripts from individuals with technical and biosecurity expertise to assist their decision.

Authors and reviewers are expected to alert the AVMA scientific editors when submitting or reviewing manuscripts with dual-use potential.

The final decision for publication as well as the means of communicating manuscripts with dual-use potential will be made by the editor-in-chief. An accompanying editorial may be published.

Editorial independence

The AVMA has adopted the following policy on editorial independence of the AJVR:

……

更多详情:

https://www.avma.org/sites/default/files/2021-06/ajvr-ifa.pdf


本文评论

暂无相应记录!

首页<<1>>尾页共0页共0条记录
  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com